Mrs. Miranda Horton Savana, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 184 Old Winnfield Rd, Jonesboro, LA 71251 Phone: 318-259-6694 Fax: 318-259-6696 |
Ali Trinh Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 184 Old Winnfield Rd, Jonesboro, LA 71251 Phone: 318-259-6694 |
Mr. Dwayne R Mitchell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 202 E Main St, Jonesboro, LA 71251 Phone: 318-259-7466 Fax: 318-259-8019 |
Jessica Clement Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 202 E Main St, Jonesboro, LA 71251 Phone: 318-259-7466 |
Lonnie Menzina, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 Alexander St, Jonesboro, LA 71251 Phone: 318-259-7334 |
Dedria Brashear, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 Alexander St, Jonesboro, LA 71251 Phone: 318-259-7334 Fax: 318-259-3013 |
Stephanie Deann Laffitte Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 202 E Main St, Jonesboro, LA 71251 Phone: 318-259-7333 |
Logan Prudhomme, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 184 Old Winnfield Rd, Jonesboro, LA 71251 Phone: 318-259-6694 |
Mr. Purvis Glen Nash, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 Holley Dr, Jonesboro, LA 71251 Phone: 318-237-5781 |
Mrs. Anita Gail Huckaby Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 Alexander St, Jonesboro, LA 71251 Phone: 318-259-7334 Fax: 318-259-3013 |
News Archive
Researchers at the University of Calgary Faculty of Medicine are using an innovative new imaging technique to study how white blood cells (called neutrophils) respond to inflammation, and have revealed new targets to inhibit the response.
Cancerous tumors are wildly unfavorable environments. Struggling for oxygen and nutrients while being bombarded by the body's defense systems, tumor cells in fact require sophisticated adaptations to survive and grow.
BioCardia, Inc., focused on regenerative biologic therapies for cardiovascular disease, today announced positive results from a Phase 1/2 heart failure trial using the Company's Helical Infusion System, comprising the Helical Infusion System Catheter and Morph Vascular Access Catheter, to deliver allogeneic, or "off-the-shelf," and autologous, or from the treated patient, mesenchymal (adult) stem cells (MSCs) via transendocardial injection.
Internet-based interventions may be effective in curbing various patterns of adult problem drinking in both community and health care settings, according to a study published December 18 in the open-access journal PLOS Medicine by Heleen Riper of VU University in Amsterdam, the Netherlands, and colleagues.
› Verified 1 days ago